Trial Subject Personal Data Clause Samples

The 'Trial Subject Personal Data' clause defines how personal information of individuals participating in a clinical trial will be collected, used, stored, and protected by the parties involved. It typically outlines the types of data that may be gathered, such as medical history or contact details, and specifies the measures taken to ensure compliance with data protection laws like GDPR. This clause is essential for safeguarding the privacy of trial subjects and ensuring that their sensitive information is handled responsibly and lawfully throughout the course of the study.
Trial Subject Personal Data. The Principal Investigator shall obtain Trial Subject written consent for the collection and use of Trial Subject personal data for Trial purposes as a condition of the Trial Subject participating in the Trial, including the disclosure, transfer and processing of data collected in accordance with the Protocol, in compliance with applicable data protection provisions.
View SourceView Similar (4)
Trial Subject Personal Data. The Principal Investigator shall obtain Trial Subject written consent for the collection and use of Trial Subject personal data for Trial purposes as a condition of the Trial Subject participating in the Trial, including the disclosure, transfer and processing of data collected in accordance with the Protocol, in compliance with applicable data protection provisions. g. The Institution consents to the disclosure of information required under the European Federation of Pharmaceutical Industries and Associations Code (“EFPIA Code”). The Principal Investigator shall ensure that any member of the Trial research staff provides their consent for the Sponsor to disclose their personal information and any amounts paid to them under this Agreement for the purposes of complying with the EFPIA Code. 12.3
View SourceView Similar (2)
Trial Subject Personal Data. The Principal
View Source
Trial Subject Personal Data. To the extent that any of the Parties access to EEA- originating Personal Data (as that term is defined in the GDPR) of Trial Subjects (“Trial Subject Personal Data”) as a result of conducting the Trial, the terms set forth in this Section 1.7 will apply. a) Osobní údaje subjektu hodnocení V rozsahu, v jakém kterákoli ze stran má přístup k osobním údajům subjektů hodnocení (jak jsou definovány v GDPR) („osobní údaje subjektů hodnocení“) v důsledku provádění klinického hodnocení, se uplatní podmínky tohoto článku 1.7. • For purposes of this Section 1.7 and Attachment A, capitalized terms used but not defined have the definitions in the GDPR unless expressly identified • Pro účely tohoto článku 1.7 a přílohy A mají výrazy napsané s velkým písmenem zde nedefinované stejný význam jako v GDPR, nejsou-li v tomto článku 1.7
View Source
Trial Subject Personal Data. The Principal Investigator shall obtain Trial Subject written consent for the collection and use of Trial Subject personal data for Trial purposes as a condition of the Trial Subject participating in the Trial, including the disclosure, transfer and processing of data collected in accordance with the Protocol, in compliance with applicable data protection provisions. Osobní údaje subjektů klinického hodnocení Hlavní zkoušející si opatří písemný souhlas subjektů klinického hodnocení se shromažďováním a použitím osobních údajů subjektů klinického hodnocení pro účely klinického hodnocení jakožto podmínku účasti subjektů klinického hodnocení na klinickém hodnocení, a to včetně zveřejnění, převodu a zpracování údajů shromážděných dle protokolu a v souladu s platnými předpisy upravujícími ochranu osobních údajů. The Institution consents to the disclosure of information required under the European Federation of Pharmaceutical Industries and Associations Code (“EFPIA Code”). The Principal Investigator shall ensure that any member of the Trial research staff provides their consent for the Sponsor to disclose their personal information and any amounts paid to them under this Agreement for the purposes of complying with the EFPIA Code. Zdravotnické zařízení souhlasí se zveřejněním povinných údajů dle kodexu Evropské federace farmaceutického průmyslu a asociací (dále jen „kodex EFPIA“). Hlavní zkoušející zajistí, aby každý výzkumný pracovník klinického hodnocení poskytl zadavateli souhlas se zveřejněním svých osobních údajů a odměn jemu vyplacených dle této smlouvy za účelem dodržení kodexu EFPIA.
View Source

Related to Trial Subject Personal Data

  • Shared Personal Data This clause sets out the framework for the sharing of personal data between the parties as data controllers. Each party acknowledges that one party (the Data Discloser) will regularly disclose to the other party (the Data Recipient) Shared Personal Data collected by the Data Discloser for the Agreed Purposes.

  • Personal Data Registry Operator shall (i) notify each ICANN-­‐accredited registrar that is a party to the registry-­‐registrar agreement for the TLD of the purposes for which data about any identified or identifiable natural person (“Personal Data”) submitted to Registry Operator by such registrar is collected and used under this Agreement or otherwise and the intended recipients (or categories of recipients) of such Personal Data, and (ii) require such registrar to obtain the consent of each registrant in the TLD for such collection and use of Personal Data. Registry Operator shall take reasonable steps to protect Personal Data collected from such registrar from loss, misuse, unauthorized disclosure, alteration or destruction. Registry Operator shall not use or authorize the use of Personal Data in a way that is incompatible with the notice provided to registrars.

  • Types of Personal Data Contact Information, the extent of which is determined and controlled by the Customer in its sole discretion, and other Personal Data such as navigational data (including website usage information), email data, system usage data, application integration data, and other electronic data submitted, stored, sent, or received by end users via the Subscription Service.

  • Your Personal Data If you determine that you will be supplying us with your Personal Data (as defined in the Data Processing Addendum referenced below) for us to process on your behalf, in the provision of maintenance and support services or hosting services (if the Product licensed to you is a Hosted Service) or during the course of any audits we conduct pursuant to section 1.14 (Audit), you may submit a written request at ▇▇▇▇▇▇▇@▇▇▇▇▇▇▇▇.▇▇▇ for the mutual execution of a Data Processing Addendum substantially in the form we make available at ▇▇▇▇▇://▇▇▇.▇▇▇▇▇▇▇▇.▇▇▇/docs/default-source/progress-software/data-processing-addendum.pdf and we will enter into such Data Processing Addendum with you. To the extent there is any conflict between this ▇▇▇▇ and such Data Processing Addendum, the Data Processing Addendum will prevail with respect to our handling and processing of your Personal Data.

  • Processing Personal Data This ▇▇▇▇▇ shall be completed by the Controller, who may take account of the view of the Processors, however the final decision as to the content of this Annex shall be with the Buyer at its absolute discretion.